Skip to main content
Clinical Trials/NCT05788562
NCT05788562
Unknown
N/A

The Relevance Between the Level of Fetal Hemoglobin and Short-term Complications in Extremely Preterm Infants

The First Hospital of Jilin University1 site in 1 country92 target enrollmentApril 1, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Fetal Hemoglobin
Sponsor
The First Hospital of Jilin University
Enrollment
92
Locations
1
Primary Endpoint
Occurrence and severity of early complications in premature infants
Last Updated
3 years ago

Overview

Brief Summary

A monocentric prospective study was conducted to find the relevance between the level of fetal hemoglobin and short-term complications in extremely preterm infants

Registry
clinicaltrials.gov
Start Date
April 1, 2023
End Date
May 30, 2024
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Preterm infants with gestational age \<32 weeks or birth weight \<1500g
  • Parents agree to attend

Exclusion Criteria

  • serious functional or organic diseases
  • severe congenital deformity
  • parents reject to attend

Outcomes

Primary Outcomes

Occurrence and severity of early complications in premature infants

Time Frame: 2022.1-2023.1

include necrotizing enterocolitis,bronchopulmonary dysplasia,retinopathy, Intraventricular hemorrhage above degree Ⅱ,leukomalacia,late-onset sepsis

Study Sites (1)

Loading locations...

Similar Trials